Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA mutation testing and association with oncologic outcome and incidence of ovarian cancer in Norway.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Feb 2025

Birgisdóttir Alda, Myklebust Tor Åge, Bjørnslett Merete, Rognlien Vibeke W, Paulsen Torbjorn, Dørum Anne

Abstract excerpt

OBJECTIVE: This study aimed to explore the frequency of BRCA mutations and testing, age at diagnosis, and incidence of ovarian cancer and to describe oncologic outcomes in patients carrying BRCA mutation compared with those not carrying mutation, in 1 cancer center that covers two-thirds of the Norwegian population. METHODS: Patients with ovarian cancer treated at Oslo University Hospital-Radiumhospital 2008-2019...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ovarian Epithelial

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Incidence

Share to Norway

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 39971428
DOI: 10.1016/j.ijgc.2024.100029

Genes

BRCA2
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA mutation testing and association with oncologic outcome and incidence of ovarian cancer in Norway.PMID 39971428Read ↗

Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study.Semantic proximity Read ↗

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer.Semantic proximity Read ↗

BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients.Semantic proximity Read ↗

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcomeSemantic proximity Read ↗

Risk reducing mastectomy in Norwegian BRCA1/2 carriers.Semantic proximity Read ↗

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.Semantic proximity Read ↗

Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian CancerSemantic proximity Read ↗

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO GuidelineSemantic proximity Read ↗

[BRCA diagnostics of ovarian cancer : Molecular tumor testing since the introduction of PARP inhibitor therapy].Semantic proximity Read ↗

Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer.Semantic proximity Read ↗

Prognostic Significance of Clinical Factors Including BRCA Mutation in Epithelial Ovarian, Peritoneal, Fallopian Tube Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.